pathogenesis of Vascular Anomalies Vascular anomalies
field of vascular anomalies
fraction of vascular anomalies
vascular biology
large collection of vascular anomalies
causative molecular alterations of vascular anomalies
Activation of PI3K signalling
understanding of PI3K activation
PI3K inhibitors
role of PI3K pathway activation
PI3K signalling pathway components
potential of repurposing PI3K pathway inhibitors
abnormal vascular elements of various types
signalling pathway drive
activation of phosphoinositide
lack of molecular understanding
pre-clinical studies
clinical aspects
lead
lesions
future clinical trials
directed therapies
project proposal
specific targeted therapies
rare soft tissue tumours
malformations
kinase
developments
infants
bleeding
laboratory
unpublished observations
infections
cellular mechanisms
maintenance
conditions
organ dysfunction
Current treatment strategies
children
young adults
clinicians
refined diagnoses
findings
moment
patientsâ€™ quality of life
high risk of recurrence
Pharma
diseases
tissues
collaborations